28th November 2016

Mirada powers Molecular Imaging on PACS .

Mirada powers Molecular Imaging on PACS

Mirada Medical is showcasing its latest XD:PACSTM range of Molecular Imaging products at the 2016 Radiological Society of North America (RSNA) Annual Meeting in Chicago, November 27 - December 1, 2016.

Mirada’s XD:PACSTM products are designed to empower Radiology and Nuclear Medicine departments seeking to integrate advanced PET/CT reading, Tumor Tracking, SPECT/CT and Nuclear Medicine analysis into the enterprise. XD:PACSTM products deliver ‘no-compromise’ functionality and feature-sets, enabling departments to dispense with the complexity and expense of having disparate legacy modality workstations and software packages. “

We have built the XD:PACSTM product range to provide state-of-the-art multi-modality applications directly from any traditional PACS or applications server, accessible at any location, through the PACS or hospital enterprise solution,” says Sarah Bond, Diagnostics Product Lifecycle Manager at Mirada Medical.

Mirada’s XD:PACSTM product range also includes latest solutions for Cardiology, Neurology, Radiation Therapy, and Tumor Board meetings.  The software comprises flexible workflows and display protocols and results can always be saved for both editing and review on PACS.

The product range is available for demonstration, along with all of Mirada’s industry-leading software, in Mirada Medical’s booth #7130 at the RSNA Annual Meeting.

About Mirada Medical

Mirada Medical is a prominent global brand in medical imaging software. Mirada’s innovative software solutions are routinely used in radiology, molecular imaging, radiation oncology and in multidisciplinary meetings throughout hospitals, imaging centers and cancer centers worldwide.  Mirada excels at combining scientifically advanced technology with practical application for diagnosis, management and treatment of cancer and other diseases